Loading...
Please wait, while we are loading the content...
Similar Documents
Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy
| Content Provider | Semantic Scholar |
|---|---|
| Author | Akin, Cem Sabato, Vito Gotlib, Jason Castells, Mariana Deininger, Michael W. N. Elberink, Hanneke Oude Heaney, Mark L. Daele, Paul L. A. Van Radia, Deepti H. Triggiani, Massimo Deangelo, Daniel J. Álvarez-Twose, Iván Broesby-Olsen, Sigurd George, Tracy I. Hartmann, Karin Frank, Siebenhaar Reiter, Andreas Vadas, Peter Bonadonna, Patrizia Panse, Jens Staubach-Renz, Petra Brockow, Knut Thąci, Diamant Lin, Hui-Min Morrison, Andrew W. Mar, Brenton G. Maurer, Marcus |
| Copyright Year | 2019 |
| Starting Page | 2950 |
| Ending Page | 2950 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| DOI | 10.1182/blood-2019-126035 |
| Alternate Webpage(s) | https://www.blueprintmedicines.com/wp-content/uploads/2020/03/Blueprint-Medicines-AAAAI-2020-Avapritinib-SM-Presentation-1.pdf |
| Alternate Webpage(s) | https://www.blueprintmedicines.com/wp-content/uploads/2020/03/Blueprint-Medicines-AAAAI-2020-Avapritinib-SM-Presentation.pdf |
| Alternate Webpage(s) | https://doi.org/10.1182/blood-2019-126035 |
| Volume Number | 134 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |